KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Current Taxes: 2009-2025

Historic Current Taxes for Ionis Pharmaceuticals (IONS) over the last 8 years, with Sep 2025 value amounting to $101,000.

  • Ionis Pharmaceuticals' Current Taxes rose 146.34% to $101,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $101,000, marking a year-over-year increase of 146.34%. This contributed to the annual value of $34,000 for FY2024, which is 98.42% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Current Taxes stood at $101,000, which was up 24.69% from $81,000 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Current Taxes registered a high of $31.1 million during Q3 2023, and its lowest value of $14,000 during Q2 2022.
  • In the last 3 years, Ionis Pharmaceuticals' Current Taxes had a median value of $284,000 in 2024 and averaged $7.1 million.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Current Taxes surged by 194,087.50% in 2023 and then plummeted by 99.87% in 2024.
  • Quarterly analysis of 5 years shows Ionis Pharmaceuticals' Current Taxes stood at $36,000 in 2021, then skyrocketed by 17,258.33% to $6.2 million in 2022, then slumped by 65.58% to $2.2 million in 2023, then tumbled by 98.42% to $34,000 in 2024, then skyrocketed by 146.34% to $101,000 in 2025.
  • Its last three reported values are $101,000 in Q3 2025, $81,000 for Q2 2025, and $126,000 during Q1 2025.